Abstract
The effects of saccharin and the opioid partial agonist buprenorphine on cocaine base smoking were evaluated in five male rhesus monkeys. Monkeys completed a sequence of responding consisting of lever-press responses maintained under a fixed-ratio (FR) schedule followed by inhalation responses (FR5) on a smoking spout to gain access to a single delivery of volatilized cocaine base (1.0 mg/kg per delivery). Monkeys could receive a maximum of ten smoke deliveries per session. In the first experiment, either saccharin (0.03% wt/vol) or water was concurrently available under an FR1 schedule through a lip-operated drinking device. As lever FR values increased from 128 to 256, 512, 1024 and 2048, the number of cocaine smoke deliveries decreased. Cocaine intake was not statistically different when water versus saccharin was concurrently available. However, as cocaine consumption decreased, saccharin intake increased demonstrating that under these conditions, saccharin was substituting for cocaine as a reinforcer. On the first day that lidocaine replaced cocaine, all of the monkeys received the maximum number of smoke deliveries (ten) and saccharin intake increased. Lever-press responding gradually extinguished over days when lidocaine (1.0 mg/kg per delivery) was available with concurrent saccharin. In the second experiment, water was concurrently available with cocaine and buprenorphine (0.01 or 0.1 mg/kg) was administered intramuscularly (IM) 30 min before the start of the session. Although pretreatment with the lower dose of buprenorphine (0.01 mg/kg) had little effect on cocaine intake overall, individual differences in cocaine intake occurred. The higher dose of buprenorphine (0.1 mg/kg) decreased the amount of cocaine consumed at all lever FR values tested.
Similar content being viewed by others
References
Bergman J, Kamien JB, Spealman, RD (1990) Antagonism of cocaine self-administration by selective dopamine D1 and D2 antagonists. Behav Pharmacol 1:355–363
Bickel WK, DeGrandpre RJ, Higgins ST, Hughes JR (1990) Behavioral economics of drug self-administration. I. Functional equivalence of response requirement and dose. Life Sci 47:1501–1510
Bickel WK, DeGrandpre RJ, Hughes JR, Higgins ST (1991) Behavioral economics of drug self-administration. II. A unit-price analysis of cigarette smoking. J Exp Anal Behav 55:145–154
Brady JV, Griffiths RR, Hienz RD, Ator NA, Lukas SE, Lamb RJ (1987) Assessing drugs for abuse liability and dependence potential in laboratory animals. In: Bozarth MA (ed) Methods of assessing the reinforcing properties of abused drugs. Springer, New York, pp 45–85
Brown EE, Finlay JM, Wong JTF, Damsma G, Fibiger HC (1991) Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for the pharmacotherapy of cocaine abuse. J Pharmacol Exp Ther 256:119–126
Carroll ME (1985) Concurrent phencyclidine and saccharin access: Presentation of an alternative reinforcer reduces drug intake. J Exp Anal Behav 43:131–144
Carroll ME, Boe IN (1982) Increased intravenous drug self-administration during deprivation of other reinforcers. Pharmacol Biochem Behav 17:563–567
Carroll ME, Boe IN (1984) Effect of dose on increased etonitazene self-administration by rats due to food deprivation. Psychopharmacology 82:151–152
Carroll ME, Lac ST (1992) Effects of buprenophine on self-administration of cocaine and a nondrug reinforcer in rats. Psychopharmacology 106:439–446
Carroll ME, Lac ST (1993) Autoshaping IV cocaine self-administration in rats: effects of nondrug alternative reinforcers on acquisition. Psychopharmacology 110:5–12
Carroll ME, Meisch RA (1984) Increased drug-reinforced behavior due to food deprivation. Adv Behav Pharmacol 4:47–88
Carroll ME, Rodefer JS (1993) Effects of income on choice between drug and an alternative nondrug reinforcer in monkeys. Exp Clin Psychopharmacol 1:110–120
Carroll ME, France CP, Meisch RA (1981) Intravenous self-administration of etonitazene, cocaine and phencyclidine in rats during food deprivation and satiation. J Pharmacol Exp Ther 217:241–247
Carroll ME, Lac ST, Nygaard SL (1989) A concurrently available nondrug reinforcer prevents the acquisition or decreases the maintenance of cocaine-reinforced behavior. Psychopharmacology 97:23–29
Carroll ME, Krattiger KL, Gieske D, Sadoff DA (1990) Cocaine-base smoking in rhesus monkeys: reinforcing and physiological effects. Psychopharmacology 102:443–450
Carroll ME, Carmona GG, May SA (1991) Modifying drug-reinforced behavior by altering the economic conditions of the drug and a nondrug reinforcer. J Exp Anal Behav 56:361–376
Carroll ME, Carmona GG, May SA, Buzalsky S, Larson C (1992) Buprenorphine's effects on self-administration of smoked cocaine base and orally delivered phencyclidine, ethanol and saccharin in rhesus monkeys. J Pharmacol Exp Ther 261:26–37
Cowan A, Lewis JW, Macfarlane IR (1977a) Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Br J Pharmacol 60:537–545
Cowan A, Doxey JC, Harry EJR (1977b) The animal pharmacology of buprenorphine, an oripavine analgesic agent. Br J Pharmacol 60:547–554
Foltin RW (1991) An economic analysis of “demand” for food in baboons. J Exp Anal Behav 56:445–454
Gastfriend DR, Mendelson JH, Mello NK, Teoh SK (1992) Preliminary results of an open trial of buprenorphine in the outpatient treatment of combined heroin and cocaine dependence. In: Harris LS (ed) Problems of drug dependence 1991 Proceedings of the 53rd Annual Scientific Meeting (National Institute of Drug Abuse Research Monograph, no. 119) US Government Printing Office, Washington DC, pp 461
Green L, Freed DE (1993) The substitutability of reinforcers. J Exp Anal Behav 60:141–158
Hursh SR (1980) Economic concepts for the analysis of behavior. J Exp Anal Behav 34:219–239
Hursh SR (1991) Behavioral economics of drug self-administration and drug abuse policy. J Exp Anal Behav 56:377–393
Hursh SR, Bauman RA (1987) The behavioral analysis of demand. In: Green L, Kagel JH (eds) Advances in behavioral economics (vol. 1). Albex, Norwood N.J., pp 117–165
Katz JL (1990) Models of relative reinforcing efficacy of drugs and their predictive utility. Behav Pharmacol 1:283–301
Kosten TA, Kleber HD, Morgan C (1989a) Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci 44:887–892
Kosten TA, Kleber HD, Morgan C (1989b) Treatment of cocaine abuse with buprenorphine. Biol Psychiatry 26:637–639
Kosten TA, Marby DW, Nestler EJ (1991) Cocaine conditioned place preference is attenuated by chronic buprenorphine treatment. Life Sci 49: PL201-PL206
Kosten TR, Rosen MI, Schottenfeld R, Ziedonis D (1992) Buprenorphine for cocaine and opiate dependence. Psychopharmacol Bull 28:15–19
Mello NK, Bree MP, Mendelson JH (1983) Comparison of buprenorphine and methadone effects on opiate self-administration in primates. J Pharmacol Exp Ther 225:378–386
Mello NK, Mendelson JH, Bree MP, Lukas SE (1989) Buprenorphine suppresses cocaine self-administration by rhesus monkeys. Science 245:859–862
Mello NK, Mendelson JH, Bree MP, Lukas SE (1990) Buprenorphine and naltrexone effects on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther 254:926–939
Mello NK, Lukas SE, Kamien JB, Mendelson JH, Drieze J, Cone EJ (1991) The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys. J Pharmacol Exp Ther 260:1185–1193
Mello NK, Kamien JB, Lukas SE, Mendelson JH, Drieze JM, Sholar JW (1993) Effects of intermittent buprenorphine administration on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther 264:530–541
Mendelson JH, Mello NK, Teoh SK, Kuehnle J, Sintavanarong P, Dooley-Coufos K (1991) Buprenorphine treatment for concurrent heroin and cocaine dependence: phase I study. In: Harris LS (ed) Problems of drug dependence 1990 Proceedings of the 52nd Annual Scientific Meeting (National Institute on Drug Abuse Research Monograph, no. 105) US Government Printing Office, Washington DC, pp 196–202
Schottenfeld RS, Pakes J, Ziedonis D, Kosten TR (1993) Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans. Biol Psychiatry 34:66–74
Winger G, Skjoldager P, Woods JH (1992) Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. J Pharmacol Exp Ther 261:311–317
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Comer, S.D., Hunt, V.R. & Carroll, M.E. Effects of concurrent saccharin availability and buprenorphine pretreatment on demand for smoked cocaine base in rhesus monkeys. Psychopharmacology 115, 15–23 (1994). https://doi.org/10.1007/BF02244746
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244746